Form 8-K - Current report:
SEC Accession No. 0001213900-21-031935
Filing Date
2021-06-10
Accepted
2021-06-10 17:00:27
Documents
1
Period of Report
2021-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea142545-8k_bostonthera.htm 8-K 28728
  Complete submission text file 0001213900-21-031935.txt   30300
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54586 | Film No.: 211008790
SIC: 2834 Pharmaceutical Preparations